Literature DB >> 25406181

Individual fertility assessment and pro-fertility counselling; should this be offered to women and men of reproductive age?

Helene W Hvidman1, Kathrine Birch Petersen2, Elisabeth C Larsen2, Kirsten Tryde Macklon2, Anja Pinborg3, Anders Nyboe Andersen2.   

Abstract

During the 1970s new contraceptive options developed and legal abortions became accessible. Family planning clinics targeting young women and men provided advice and assistance on contraception. Today, delayed childbearing, low total fertility rates and increasing use of social oocyte freezing create a need for pro-fertility initiatives. Three years ago we established a new separate unit: The Fertility Assessment and Counselling (FAC) clinic. The FAC clinic offers free individual counselling based on a clinical assessment including measurement of serum anti-Müllerian hormone and ovarian and pelvic sonography in women, sperm analysis in men, and a review of reproductive risk factors in both sexes. The FAC clinic includes a research programme with the goal to improve prediction and protection of fertility. Our first proposition is that clinics for individual assessment and counselling need to be established, as there is a strong unmet demand among women and men to obtain: (i) knowledge of fertility status, (ii) knowledge of reproductive lifespan (women) and (iii) pro-fertility advice. Addressing these issues is often more challenging than treating infertile patients. Therefore, we propose that fertility assessment and counselling should be developed by specialists in reproductive medicine. There are two main areas of concern: As our current knowledge on reproductive risk factors is primarily based on data from infertile patients, the first concern is how precisely we are able to forecast future reproductive problems. Predictive parameters from infertile couples, such as duration of infertility, are not applicable, diagnostic factors like tubal patency are unavailable and other parameters may be unsuitable when applied to the general population. Therefore, strict validation of reproductive forecasting in women and men from the general population is crucial. The second main concern is that we may turn clients into patients. Screening including reproductive forecasting may induce unnecessary anxiety through false positive predictions and may even result in overtreatment in contrast to the intended preventive concept. False negative findings may create false reassurance and result in postponement of conceptions.
© The Author 2014. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  anti-Müllerian hormone; family planning; prediction fertility; reproductive lifespan; reproductive risk

Mesh:

Substances:

Year:  2014        PMID: 25406181     DOI: 10.1093/humrep/deu305

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  19 in total

1.  Awareness of the effects of postponing motherhood among hospital gynecologists: is their knowledge sufficient to offer appropriate help to patients?

Authors:  Alberto Revelli; Alessandra Razzano; Luisa Delle Piane; Simona Casano; Chiara Benedetto
Journal:  J Assist Reprod Genet       Date:  2016-01-04       Impact factor: 3.412

2.  Counseling patients on reproductive aging and elective fertility preservation-a survey of obstetricians and gynecologists' experience, approach, and knowledge.

Authors:  Rani Fritz; Susan Klugman; Harry Lieman; Jay Schulkin; Laura Taouk; Neko Castleberry; Erkan Buyuk
Journal:  J Assist Reprod Genet       Date:  2018-08-02       Impact factor: 3.412

3.  Novel correlates between antimüllerian hormone and menstrual cycle characteristics in African-American women (23-35 years-old).

Authors:  Erica E Marsh; Lia A Bernardi; Marissa L Steinberg; Peter J de Chavez; Jenny A Visser; Mercedes R Carnethon; Donna D Baird
Journal:  Fertil Steril       Date:  2016-04-23       Impact factor: 7.329

4.  Guidelines informing counseling on female age-related fertility decline: a systematic review.

Authors:  Emma Trawick; Jillian Pecoriello; Gwendolyn Quinn; Kara N Goldman
Journal:  J Assist Reprod Genet       Date:  2020-11-14       Impact factor: 3.412

5.  Attitudes towards family formation among men attending fertility counselling.

Authors:  R Sylvest; E Koert; K Birch Petersen; G M H Malling; F Hald; A Nyboe Andersen; L Schmidt
Journal:  Reprod Biomed Soc Online       Date:  2018-07-20

6.  Intention of having a second child among infertile and fertile women attending outpatient gynecology clinics in three major cities in China: a cross-sectional study.

Authors:  Bobo Hi-Po Lau; Ran Huo; Kun Wang; Li Shi; Rong Li; Sha Mu; Hongmei Peng; Yu Wang; Xiujuan Chen; Ernest Hung-Yu Ng; Celia Hoi-Yan Chan
Journal:  Hum Reprod Open       Date:  2018-09-25

7.  Two-year follow-up of a randomized controlled trial: knowledge and reproductive outcome after online fertility education.

Authors:  Eri Maeda; Jacky Boivin; Satoshi Toyokawa; Katsuyuki Murata; Hidekazu Saito
Journal:  Hum Reprod       Date:  2018-11-01       Impact factor: 6.918

8.  Evidence of profound ovarian suppression on combined hormonal contraception resulting in dramatically different ovarian reserve testing and oocyte retrieval outcomes: case report and review of the literature.

Authors:  Chelsea W Fox; Jamie Stanhiser; Alexander M Quaas
Journal:  F S Rep       Date:  2020-09-02

9.  Development of a health promotion programme to improve awareness of factors that affect fertility, and evaluation of its reach in the first 5 years.

Authors:  Karin Hammarberg; Robert J Norman; Sarah Robertson; Robert McLachlan; Janet Michelmore; Louise Johnson
Journal:  Reprod Biomed Soc Online       Date:  2017-07-08

10.  An evaluation of comprehensiveness, feasibility and acceptability of a fertility awareness educational tool.

Authors:  R R Bayoumi; S van der Poel; E Z El Samani; J Boivin
Journal:  Reprod Biomed Soc Online       Date:  2018-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.